156 related articles for article (PubMed ID: 12703219)
41. Hepatectomy and pancreatectomy with combined vascular resection in patients with hepato-biliary and pancreas diseases at a single cancer institute.
Nanashima A; Yamaguchi H; Sumida Y; Abo T; Tobinaga S; Tanaka K; Takeshita H; Hidaka S; Sawai T; Yasutake T; Nagayasu T
Hepatogastroenterology; 2008; 55(84):873-8. PubMed ID: 18705286
[TBL] [Abstract][Full Text] [Related]
42. Consensus and controversy in the management of hepatocellular carcinoma.
Kim RD; Reed AI; Fujita S; Foley DP; Mekeel KL; Hemming AW
J Am Coll Surg; 2007 Jul; 205(1):108-23. PubMed ID: 17617340
[No Abstract] [Full Text] [Related]
43. Transarterial chemoembolization for hepatocellular carcinoma.
Lau WY; Yu SC; Lai EC; Leung TW
J Am Coll Surg; 2006 Jan; 202(1):155-68. PubMed ID: 16377509
[No Abstract] [Full Text] [Related]
44. Selecting patients with hepatocellular carcinoma for transplantation.
Piscaglia F; Gianstefani A; Righini R; Bolondi L
Liver Transpl; 2007 Aug; 13(8):1203; author reply 1204. PubMed ID: 17663399
[No Abstract] [Full Text] [Related]
45. Downstaging hepatocellular carcinoma prior to liver transplantation.
Gamblin TC; Geller DA
Liver Transpl; 2005 Dec; 11(12):1466-8. PubMed ID: 16315292
[No Abstract] [Full Text] [Related]
46. Predicting survival in early hepatocellular carcinoma.
Ryder S
Gut; 2005 Mar; 54(3):328-9. PubMed ID: 15710977
[No Abstract] [Full Text] [Related]
47. Issue in statistical strategy in case-control study.
Li XY; Bai MJ; Chen LJ; Xu JL; Lin ZH; Li X; Xing YF
Hepatology; 2015 Jul; 62(1):320. PubMed ID: 25477185
[No Abstract] [Full Text] [Related]
48. Liver transplantation for primary sclerosing cholangitis; predictors and consequences of hepatobiliary malignancy.
Brandsaeter B; Isoniemi H; Broomé U; Olausson M; Bäckman L; Hansen B; Schrumpf E; Oksanen A; Ericzon BG; Höckerstedt K; Mäkisalo H; Kirkegaard P; Friman S; Bjøro K
J Hepatol; 2004 May; 40(5):815-22. PubMed ID: 15094230
[TBL] [Abstract][Full Text] [Related]
49. Management of hepatocellular carcinoma.
Del Pozo AC; López P
Clin Liver Dis; 2007 May; 11(2):305-21. PubMed ID: 17606209
[TBL] [Abstract][Full Text] [Related]
50. Adjuvant conversion to sirolimus in liver transplant patients with recurrent hepatocellular carcinoma - preliminary results.
Kornberg A; Küpper B; Tannapfel A; Thrum K; Wilberg J; Bärthel E; Settmacher U
Transpl Int; 2008 Jan; 21(1):96-9. PubMed ID: 17903182
[No Abstract] [Full Text] [Related]
51. [Diagnosis and treatment of multicentric occurrence of hepatocellular carcinoma].
He ZP
Zhonghua Gan Zang Bing Za Zhi; 2004 Mar; 12(3):187-9. PubMed ID: 15059316
[No Abstract] [Full Text] [Related]
52. A case report of hepatocellular carcinoma and focal nodular hyperplasia with a myelolipoma in two chimpanzees and a review of spontaneous hepatobiliary tumors in non-human primates.
Porter BF; Goens SD; Brasky KM; Hubbard GB
J Med Primatol; 2004 Feb; 33(1):38-47. PubMed ID: 15061732
[TBL] [Abstract][Full Text] [Related]
53. Surgical oncologist and liver cancer expert Dr. Tim Pawlik on the potential of pharmacological and surgical approaches in biliary tract cancer.
Pawlik TM
Expert Opin Investig Drugs; 2021 Apr; 30(4):299-300. PubMed ID: 33455466
[No Abstract] [Full Text] [Related]
54. A phase II study of lapatinib in patients with advanced biliary tree and hepatocellular cancer.
Ramanathan RK; Belani CP; Singh DA; Tanaka M; Lenz HJ; Yen Y; Kindler HL; Iqbal S; Longmate J; Mack PC; Lurje G; Gandour-Edwards R; Dancey J; Gandara DR
Cancer Chemother Pharmacol; 2009 Sep; 64(4):777-83. PubMed ID: 19169683
[TBL] [Abstract][Full Text] [Related]
55. Transcatheter arterial chemoembolization in hepatocellular carcinoma: technique, effects and present status.
Paul SB; Guglani B; Gulati MS; Batra Y; Mukhopadhyay S
Trop Gastroenterol; 2003; 24(4):176-84. PubMed ID: 15164527
[No Abstract] [Full Text] [Related]
56. Staging systems for hepatocellular carcinoma: should we all use the BCLC system?
Marrero JA
J Hepatol; 2006 Apr; 44(4):630-2. PubMed ID: 16503077
[No Abstract] [Full Text] [Related]
57. Sustained complete response and low complication rates after radiofrequency ablation of very early hepatocellular carcinoma in cirrhosis.
Cho YK; Kim JK
Hepatology; 2008 May; 47(5):1791; author reply 1791. PubMed ID: 18393364
[No Abstract] [Full Text] [Related]
58. Uncharacteristically early fatal intraperitoneal rupture of hepatocellular carcinoma following transarterial chemoembolization.
Reichman TW; Anthony T; Millis JM; Testa G
Dig Liver Dis; 2009 Feb; 41(2):175-6. PubMed ID: 18849205
[No Abstract] [Full Text] [Related]
59. Technologies for ablation of hepatocellular carcinoma.
Callstrom MR; Charboneau JW
Gastroenterology; 2008 Jun; 134(7):1831-5. PubMed ID: 18486619
[No Abstract] [Full Text] [Related]
60. A case of well-differentiated hepatocellular carcinoma arising in primary biliary cirrhosis.
Yano Y; Yoon S; Seo Y; Ninomiya T; Nagano H; Nakaji M; Hayashi Y; Kasuga M
Kobe J Med Sci; 2003; 49(1-2):39-43. PubMed ID: 12796567
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
